Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-29 @ 5:35 PM
Study NCT ID:
NCT01217450
Status:
COMPLETED
Last Update Posted:
2014-05-29
First Post:
2010-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
Sponsor:
National Cancer Institute (NCI)